Join Us

Graham A. Colditz, M.D., Dr.P.H.

Save as Favorite
Sign in to receive recommendations (Learn more)
Graham colditz small

Dr. Colditz is an internationally known epidemiologist and public health expert with a longstanding interest in the causes and prevention of chronic disease, particularly among women. From 1996 to 2006, he was the principal investigator of the Nurses’ Health Study, one of the largest and longest running investigations of factors that influence women’s health.

After 23 years at Harvard University, Dr. Colditz joined the Washington University School of Medicine faculty in 2006 to serve as the Niess-Gain Professor and associate director of Prevention and Control at the Siteman Cancer Center. In 2010, Dr. Colditz was named chief of the Division of Public Health Sciences in the Department of Surgery. He also serves as program director for the School of Medicine’s Master of Population Health Sciences degree program.

With a commitment to identifying preventable causes of chronic disease among women and adolescents, Dr. Colditz continues to study benign breast disease and other markers for risk of breast cancer. He developed the award-winning Your Disease Risk website, which communicates tailored prevention messages to the public. Dr. Colditz has published over 850 peer-reviewed publications, six books, and six reports for the Institute of Medicine, National Academies of Health.

Dr. Colditz was the editor-in-chief of the journal Cancer Causes and Control and has contributed to reports of the Surgeon General on Tobacco and Health. He has served on several committees for the National Academies of Science and the National Cancer Institute, among others. In 2011, Dr. Colditz was awarded the American Cancer Society Medal of Honor for cancer control research.

Was this article helpful? Yes / No
Rn icon

Can we help guide you?

Create a profile for better recommendations

  • Breast Cancer Stages

    The stage of a breast cancer is determined by the cancer’s characteristics, such as how large it...

  • HER2 Status

    HER2 (human epidermal growth factor receptor 2) is a gene that can play a role in the development...

  • Ductal Carcinoma In Situ (DCIS)

    Ductal carcinoma in situ (DCIS) is non-invasive breast cancer. Ductal means that the cancer...

Beta How does this work? Learn more

Covid19 sidebar v04.4
Back to Top